Treatment Issues Related to the Use of Psychedelics, Trichotillomania, Social Anxiety Disorder, Schizophrenia, and Opioid Use Disorder
This issue of the Journal brings together clinically relevant papers, several of which are focused on new treatment development. The issue begins with an overview from Drs. Bryan Roth and Ryan Gumpper (1) that is very timely, given the high level of interest in psychedelics and the related emerging clinical trial data. In addition to discussing potential...